IOBT |
IO Biotech, Inc. |
Jul 25, 2024 |
2 |
-$99.1K |
4 |
Jul 26, 2024 |
10%+ Owner |
IOBT |
IO Biotech, Inc. |
May 10, 2024 |
1 |
-$802K |
4 |
May 14, 2024 |
10%+ Owner |
SPRB |
SPRUCE BIOSCIENCES, INC. |
Mar 21, 2024 |
1 |
-$351K |
4 |
Mar 25, 2024 |
10%+ Owner |
SPRB |
SPRUCE BIOSCIENCES, INC. |
Mar 18, 2024 |
3 |
-$1.36M |
4 |
Mar 20, 2024 |
10%+ Owner |
SPRB |
SPRUCE BIOSCIENCES, INC. |
Mar 14, 2024 |
1 |
-$1.7M |
4 |
Mar 18, 2024 |
10%+ Owner |
MGX |
Metagenomi, Inc. |
Feb 9, 2024 |
5 |
$13M |
4 |
Feb 15, 2024 |
10%+ Owner |
IOBT |
IO Biotech, Inc. |
Feb 9, 2024 |
1 |
-$988K |
4 |
Feb 13, 2024 |
10%+ Owner |
MGX |
Metagenomi Technologies, LLC |
Feb 8, 2024 |
0 |
$0 |
3 |
Feb 8, 2024 |
10%+ Owner |
IOBT |
IO Biotech, Inc. |
Aug 9, 2023 |
2 |
$10M |
4 |
Aug 11, 2023 |
10%+ Owner |
CYT |
Cyteir Therapeutics, Inc. |
Jul 19, 2023 |
2 |
-$280K |
4 |
Jul 20, 2023 |
10%+ Owner |
CYT |
Cyteir Therapeutics, Inc. |
Jul 14, 2023 |
3 |
-$106K |
4 |
Jul 18, 2023 |
10%+ Owner |
CYT |
Cyteir Therapeutics, Inc. |
Jun 30, 2023 |
1 |
-$529K |
4 |
Jul 3, 2023 |
10%+ Owner |
IRON |
Disc Medicine, Inc. |
Jun 28, 2023 |
1 |
-$57.6M |
4 |
Jun 28, 2023 |
10%+ Owner |
CYT |
Cyteir Therapeutics, Inc. |
Jun 26, 2023 |
2 |
-$71.8K |
4 |
Jun 28, 2023 |
10%+ Owner |
RPHM |
Reneo Pharmaceuticals, Inc. |
Jun 23, 2023 |
1 |
-$710K |
4 |
Jun 23, 2023 |
10%+ Owner |
CYT |
Cyteir Therapeutics, Inc. |
Jun 21, 2023 |
3 |
-$25.9K |
4 |
Jun 23, 2023 |
10%+ Owner |
CYT |
Cyteir Therapeutics, Inc. |
Jun 15, 2023 |
3 |
-$34K |
4 |
Jun 20, 2023 |
10%+ Owner |
CYT |
Cyteir Therapeutics, Inc. |
Jun 12, 2023 |
3 |
-$13.4K |
4 |
Jun 14, 2023 |
10%+ Owner |
SPRB |
SPRUCE BIOSCIENCES, INC. |
Feb 16, 2023 |
2 |
$7M |
4 |
Feb 21, 2023 |
10%+ Owner |
IRON |
Disc Medicine, Inc. |
Dec 29, 2022 |
0 |
$0 |
3 |
Jan 3, 2023 |
10%+ Owner |
EWTX |
Edgewise Therapeutics, Inc. |
Sep 14, 2022 |
1 |
$5M |
4 |
Sep 16, 2022 |
10%+ Owner |
CYT |
Cyteir Therapeutics, Inc. |
Jul 20, 2022 |
1 |
-$2.7M |
4 |
Jul 22, 2022 |
10%+ Owner |
BOLT |
Bolt Biotherapeutics, Inc. |
Jul 13, 2022 |
1 |
-$1.6M |
4 |
Jul 15, 2022 |
10%+ Owner |
CMPI |
Checkmate Pharmaceuticals, Inc. |
Feb 23, 2022 |
3 |
-$23.1K |
4 |
Feb 25, 2022 |
10%+ Owner |
ACLX |
Arcellx, Inc. |
Feb 8, 2022 |
6 |
$12.5M |
4 |
Feb 9, 2022 |
10%+ Owner |
ACLX |
Arcellx, Inc. |
Feb 3, 2022 |
0 |
$0 |
3 |
Feb 3, 2022 |
10%+ Owner |
IOBT |
IO Biotech, Inc. |
Nov 9, 2021 |
4 |
$4.55M |
4 |
Nov 10, 2021 |
10%+ Owner |
IOBT |
IO Biotech, Inc. |
Nov 4, 2021 |
0 |
$0 |
3 |
Nov 4, 2021 |
10%+ Owner |
UTRS |
MINERVA SURGICAL INC |
Oct 26, 2021 |
5 |
$1.41M |
4 |
Oct 27, 2021 |
10%+ Owner |
UTRS |
MINERVA SURGICAL INC |
Oct 21, 2021 |
0 |
$0 |
3 |
Oct 21, 2021 |
10%+ Owner |
CYT |
Cyteir Therapeutics, Inc. |
Jun 22, 2021 |
4 |
$5M |
4 |
Jun 23, 2021 |
10%+ Owner |
VERV |
Verve Therapeutics, Inc. |
Jun 21, 2021 |
3 |
$6.65M |
4 |
Jun 22, 2021 |
10%+ Owner |
CYT |
Cyteir Therapeutics, Inc. |
Jun 17, 2021 |
0 |
$0 |
3 |
Jun 17, 2021 |
10%+ Owner |
VERV |
Verve Therapeutics, Inc. |
Jun 16, 2021 |
0 |
$0 |
3 |
Jun 16, 2021 |
10%+ Owner |
INGN |
Inogen Inc |
Jun 2, 2021 |
1 |
-$39M |
4 |
Jun 3, 2021 |
10%+ Owner |
SPRB |
SPRUCE BIOSCIENCES, INC. |
May 19, 2021 |
1 |
-$6.6M |
4 |
May 21, 2021 |
10%+ Owner |